Purpose To describe the genetic landscape and clinical characteristics of Chinese patients
diagnosed with papillary thyroid cancer (PTC) and to determine which high-risk genetic …

Background The genetic alterations of papillary thyroid carcinoma (PTC) have been
reported to change over the past few decades. We performed this systematic review to …

Background To determine the relevance of the single or combination mutations of BRAF
V600E, TERT, and NRAS genes and the clinicopathologic relationship in papillary thyroid …

Objective: To evaluate the significance of BRAF V600E and Ras mutations, and RET
rearrangements in papillary thyroid cancer (PTC) in the South central region of China …

Improvement in the clinical outcome of human cancers requires characterization of the
genetic alterations underlying their pathogenesis. Large‐scale genomic and transcriptomic …

Introduction The use of molecular markers, especially BRAF and TERT promoter mutations,
for risk stratification in papillary thyroid carcinoma (PTC) is subject to continuing debate. In …

Purpose Papillary thyroid carcinomas (PTCs) frequently involve genetic alterations. The
objective of this study was to investigate genetic alterations and further explore the …

Background The objective of this study was to investigate genetic variations and the
relationships between these genetic variations and clinicopathological features of high …

Background To investigate the significance of multi-gene assay in papillary thyroid
carcinoma (PTC) patients in clinical practice. Methods From April to December 2019 …

Purpose To investigate the prognostic value of the BRAF V600E mutation and the recently
identified TERT promoter mutation chr5: 1,295,228 C> T (C228T), individually and in their …